US Map / Texas
State TX

Clinical Trials in Texas

Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.

Total Trials
736
Recruiting Now
736
← Back to US Map
Top Conditions in Texas
Breast Cancer (17)Prostate Cancer (15)Colorectal Cancer (12)Advanced Solid Tumors (11)Advanced Solid Tumor (11)Acute Myeloid Leukemia (10)Ovarian Cancer (10)Endometrial Cancer (9)Asthma (8)Multiple Myeloma (7)Cancer (7)Chronic Lymphocytic Leukemia (7)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 736 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 736. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT05913908 N/A
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Enrollment
15 pts
Location
United States, Poland
Sponsor
CroiValve Limited
View Trial →
NCT06400004 Phase 3
Recruiting
Lumason® Infusion vs. Bolus Administrations
Condition
Heart Diseases
Enrollment
106 pts
Location
United States
Sponsor
Bracco Diagnostics, Inc
View Trial →
NCT07112404 N/A
Recruiting
Pain Intervention With Needling: Pilot Of Integrated Neuromodulation Techniques
Condition
Pain
Enrollment
42 pts
Location
United States
Sponsor
The University of Texas Medica
View Trial →
NCT06004882 N/A
Recruiting
Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy Wit...
Condition
Peripheral Nerve Stimulation
Enrollment
45 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07556159 N/A
Recruiting
A Study Evaluating Disease Characteristics and Outcomes in Participants With Ast...
Condition
Asthma
Enrollment
2,500 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT06744816 EARLY_Phase 1
Recruiting
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced P...
Condition
Peripheral Neuropathy Due to Chemotherapy
Enrollment
20 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT04752774 Phase 1, Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With...
Condition
Spasticity
Enrollment
240 pts
Location
United States, Austria, Bulgaria
Sponsor
Ipsen
View Trial →
NCT06261060 Phase 2
Recruiting
Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Fam...
Condition
Familial Platelet Disorder
Enrollment
6 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06842784 N/A
Recruiting
Impact of Extreme Heat on Myocardial Blood Flow and Flow Reserve in Young and Ol...
Condition
Aging
Enrollment
24 pts
Location
United States
Sponsor
University of Texas Southweste
View Trial →
NCT05169515 Phase 1
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab o...
Condition
Non-Hodgkin Lymphoma
Enrollment
121 pts
Location
United States, Israel, Italy
Sponsor
Hoffmann-La Roche
View Trial →
NCT05219617 Phase 3
Recruiting
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizu...
Condition
Seizures
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
SK Life Science, Inc.
View Trial →
NCT06050733 N/A
Recruiting
The Gut Microbiome and Immunotherapy Response in Solid Cancers
Condition
Cancer
Enrollment
16 pts
Location
United States
Sponsor
The University of Texas Medica
View Trial →
NCT05301140 N/A
Recruiting
Vivistim Registry for Paired VNS Therapy (GRASP)
Condition
Upper Extremity Problem
Enrollment
1,000 pts
Location
United States
Sponsor
MicroTransponder Inc.
View Trial →
NCT04655404 EARLY_Phase 1
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK F...
Condition
High Grade Glioma
Enrollment
15 pts
Location
United States, Australia, Canada
Sponsor
Nationwide Children's Hospital
View Trial →
NCT05573126 Phase 1, Phase 2
Recruiting
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients...
Condition
Hormone Receptor-positive Breast Cancer
Enrollment
95 pts
Location
United States, Spain, United Kingdom
Sponsor
Ellipses Pharma
View Trial →
NCT07246590 Phase 3
Recruiting
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2...
Condition
Common Warts
Enrollment
300 pts
Location
United States
Sponsor
Verrica Pharmaceuticals Inc.
View Trial →
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT06544876 N/A
Recruiting
Balance Control and Recovery in Diabetes Peripheral Neuropathy
Condition
Diabetic Peripheral Neuropathy
Enrollment
60 pts
Location
United States
Sponsor
Lisa Griffin
View Trial →
NCT05331170 Phase 2
Recruiting
Viral Mucosal Reprogramming
Condition
Asthma
Enrollment
75 pts
Location
United States
Sponsor
The University of Texas Medica
View Trial →
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03294954 Phase 1
Recruiting
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Chi...
Condition
Neuroblastoma
Enrollment
70 pts
Location
United States
Sponsor
Baylor College of Medicine
View Trial →
NCT06967805 Phase 2
Recruiting
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
164 pts
Location
United States, Argentina, Australia
Sponsor
Mediar Therapeutics
View Trial →
NCT05692180 Phase 3
Recruiting
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Tim...
Condition
Asthma
Enrollment
200 pts
Location
United States, Argentina, Canada
Sponsor
AstraZeneca
View Trial →
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
View Trial →
NCT05541705 N/A
Recruiting
Treadmill Oscillation Walking to Improve Weight Transfer During Gait Following S...
Condition
Treadmill Walking
Enrollment
15 pts
Location
United States
Sponsor
University of Texas at Austin
View Trial →
Page 3 of 30 — 736 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology